Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK4 | O00444 | 1/20 | 0.47 |
| ▸ | AURKA | O14965 | 1/20 | 0.47 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.47 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.47 |
| ▸ | CDK1 | P06493 | 1/20 | 0.47 |
| ▸ | PIM1 | P11309 | 1/20 | 0.47 |
| ▸ | PRKACA | P17612 | 1/20 | 0.47 |
| ▸ | CDK2 | P24941 | 1/20 | 0.47 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.47 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.47 |
| ▸ | GSK3A | P49840 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.47 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.47 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.47 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.47 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.47 |
| ▸ | SGK2 | Q9HBY8 | 1/20 | 0.47 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.47 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15319514 | 0.86 | DAPK3 (0.51) | PLK4AURKADAPK3CHEK2CDK1 | |
| SCHEMBL22777793 | 0.78 | DHODH (0.50) | PLK4AURKADAPK3CHEK2CDK1 | |
| SCHEMBL29448043 | 0.78 | DHODH (0.50) | PLK4AURKADAPK3CHEK2CDK1 | |
| SCHEMBL22777732 | 0.76 | BCL2L1 (0.51) | PLK4AURKADAPK3CHEK2CDK1 | |
| SCHEMBL29448037 | 0.76 | BCL2L1 (0.51) | PLK4AURKADAPK3CHEK2CDK1 | |
| SCHEMBL30522325 | 0.75 | NPC1 (0.45) | SMN1; SMN2LMNANFKB1NFKB2RELA | |
| SCHEMBL29947323 | 0.74 | PIM1 (0.54) | PLK4AURKADAPK3CHEK2CDK1 | |
| SCHEMBL22777740 | 0.73 | MEN1 (0.45) | SMN1; SMN2LMNANFKB1NFKB2RELA | |
| SCHEMBL22777755 | 0.72 | HPGD (0.46) | CHEK2SMN1; SMN2LMNAKDM4EMEN1 | |
| SCHEMBL22777810 | 0.72 | HDAC1 (0.49) | SMN1; SMN2LMNANFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220304984-A1 | AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF | VANDERBILT UNIVERSITY | 2022-09-29 | — | — | US | claimed |
| EP-3983084-A1 | AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF | Vanderbilt University (US) | 2022-04-20 | — | — | EP | claimed |
| CN-114222729-A | Amino acid transport inhibitors and uses thereof | 范德比尔特大学 | 2022-03-22 | — | — | CN | claimed |
| WO-2020252353-A1 | AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF | VANDERBILT UNIVERSITY (US) | 2020-12-17 | — | — | WO | claimed |
| US-20220304984-A1 | AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF | VANDERBILT UNIVERSITY | 2022-09-29 | — | — | US | disclosed |
| WO-2020252353-A1 | AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF | VANDERBILT UNIVERSITY (US) | 2020-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220304984-A1 | AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF | SLC1A5, SLC7A11, SLC3A2 | PLK4 2362/4885AURKA 1951/4885DAPK3 2793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.